Clinical Trial

Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia

Name: Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia — clinical trial record (NCT07144020)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

A Clinical Study on the Safety and Effectiveness of Donor Derived CD117 CAR-T Cell in the treatment of Relapsed/Refractory Acute Myeloid Leukemia

Trial Details

NCT Number	NCT07144020
Lead Sponsor	Zhejiang University Collaborators: Yake Biotechnology Ltd.
Conditions	Acute Myeloid Leukemia
Enrollment	50 participants
Start Date	2025-09-05
Primary Completion	2028-09-05 (estimated)
Study Completion	2028-09-05 (estimated)
Updated on ClinicalTrials.gov	2025-08-27